NYSEARCA:IHE - iShares US Pharmaceuticals ETF Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$151.8848 +2.50 (+1.68 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$149.3816
Today's Range$149.57 - $151.89
52-Week Range$131.91 - $170.26
Volume7,351 shs
Average Volume13,382 shs
Market Capitalization$394.90 million
P/E RatioN/A
Dividend Yield1.18%
BetaN/A
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors.

Receive IHE News and Ratings via Email

Sign-up to receive the latest news and ratings for IHE and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer BlackRock
Fund NameiShares US Pharmaceuticals ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IHE
Inception Date5/1/2006
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkDJ US Select Pharms TR USD
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$388.39 million
Average Daily Volume$14,335.00
Discount/Premium-1.65%

ETF Expenses

Management Fee0.44%
Other Expenses0.00%
Total Expenses0.44%
Fee Waiver0.00%
Net Expenses0.44%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerIMC Chicago

Geographic Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
Currency Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
Sector Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
Industry Exposure of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

iShares US Pharmaceuticals ETF (NYSEARCA:IHE) Frequently Asked Questions

What is iShares US Pharmaceuticals ETF's stock symbol?

iShares US Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IHE."

How often does iShares US Pharmaceuticals ETF pay dividends? What is the dividend yield for iShares US Pharmaceuticals ETF?

iShares US Pharmaceuticals ETF announced a quarterly dividend on Monday, December 17th. Investors of record on Tuesday, December 18th will be paid a dividend of $0.3505 per share on Friday, December 21st. This represents a $1.40 dividend on an annualized basis and a dividend yield of 0.92%. The ex-dividend date is Monday, December 17th. View iShares US Pharmaceuticals ETF's Dividend History.

Has iShares US Pharmaceuticals ETF been receiving favorable news coverage?

Press coverage about IHE stock has trended positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. iShares US Pharmaceuticals ETF earned a news sentiment score of 2.7 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future.

Who are iShares US Pharmaceuticals ETF's key executives?

iShares US Pharmaceuticals ETF's management team includes the folowing people:
  • George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees (Age 78)
  • Michael Arthur Latham, President, Trustee (Age 51)
  • Jack Gee, Chief Financial Officer, Treasurer (Age 57)
  • Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
  • Amy Schioldager, Executive Vice President (Age 56)
  • Ira P. Shapiro, Vice President, Chief Legal Officer (Age 52)
  • Matt Tucker, Vice President
  • Eilleen M. Clavere, Secretary (Age 61)
  • Cecilia H. Herbert, Independent Trustee (Age 68)
  • Charles A. Hurty, Independent Trustee (Age 73)

Who are iShares US Pharmaceuticals ETF's major shareholders?

iShares US Pharmaceuticals ETF's stock is owned by many different of retail and institutional investors. Top institutional investors include Brown Advisory Inc. (2.33%), Colony Group LLC (2.14%), Biegel & Waller LLC (1.45%), Bank of America Corp DE (1.05%), Murphy Capital Management Inc. (1.00%) and Commonwealth Equity Services LLC (0.80%).

Which institutional investors are selling iShares US Pharmaceuticals ETF stock?

IHE stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Raymond James & Associates, Raymond James Financial Services Advisors Inc., Brown Advisory Inc., Wealthstreet Investment Advisors LLC, LPL Financial LLC, Karp Capital Management Corp and Adviser Investments LLC.

Which institutional investors are buying iShares US Pharmaceuticals ETF stock?

IHE stock was acquired by a variety of institutional investors in the last quarter, including Colony Group LLC, Biegel & Waller LLC, Ferguson Wellman Capital Management Inc., Mawer Investment Management Ltd., Commonwealth Equity Services LLC, BB&T Securities LLC, Citigroup Inc. and Essex Savings Bank.

How do I buy shares of iShares US Pharmaceuticals ETF?

Shares of IHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is iShares US Pharmaceuticals ETF's stock price today?

One share of IHE stock can currently be purchased for approximately $151.8848.

How big of a company is iShares US Pharmaceuticals ETF?

iShares US Pharmaceuticals ETF has a market capitalization of $394.90 million.

What is iShares US Pharmaceuticals ETF's official website?

The official website for iShares US Pharmaceuticals ETF is http://www.iShares.com.


MarketBeat Community Rating for iShares US Pharmaceuticals ETF (NYSEARCA IHE)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  15 (Vote Underperform)
Total Votes:  36
MarketBeat's community ratings are surveys of what our community members think about iShares US Pharmaceuticals ETF and other stocks. Vote "Outperform" if you believe IHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2019 by MarketBeat.com Staff

Featured Article: Why do corrections happen?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel